Nxera Pharma is a Japan-based, research-driven biopharmaceutical company specializing in the development of innovative medicines. By leveraging its proprietary platform, Nxera Pharma focuses on the discovery of novel therapeutic agents to address complex and challenging diseases.
Date confirmed from the Tokyo Stock Exchange (JPX) announcement schedule.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Nxera Pharma is scheduled to report its next quarterly earnings on 10/30/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Nxera Pharma last reported quarterly earnings on 8/7/2026 (Q2 2026). Earnings per share (EPS) came in at -2.28 JPY.
Across its last 3 earnings reports, Nxera Pharma stock moved by ±1.1% on average the following day. The largest reaction was -2% on 05/01/2026; 0 of 3 reactions were positive.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.